Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Diabetes
•
Male and Female Reproductive Disorders
•
Primary Care
Do you regularly counsel younger women of childbearing age about the impact of Tirzepatide on oral hormonal contraception?
https://pubmed.ncbi.nlm.nih.gov/37940101/
Related Questions
How do you counsel patients on the use of compounded weight loss medications?
Does oral semaglutide provide similar cardiovascular risk reduction benefits as injectable semaglutide?
When do you recommend screening patients with T2DM for heart failure?
How would you work-up an older male patient with elevated testosterone-level-for-age?
In a young male patient with hypogonadotropic hypogonadism and fertility goals, would starting testosterone replacement therapy affect fertility chances?
When and how should we be stopping GLP-1 Receptor Agonist/Dual Agonist therapy?
Do you recommend the use of Korlym (Mifepristone) for patients with difficult to control diabetes and evidence of mild endogenous hypercortisolism of unknown source?
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
Does your decision to start or continue Ozempic therapy in patients with diabetic retinopathy depend on the severity of the retinopathy?
What is your approach to patients with persistent low libido despite normal testosterone levels after use of exogenous testosterone replacement therapy?